McDonald's CEO, Chris Kempczinski, said that the $5 deal is "driving other purchases," raising the average check "north of ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in P ...

Fast-food giant reports weaker profit; international markets show progress.

McDonald's Corp. is pushing ahead with ambitious expansion plans for 2025, announcing approximately 2,200 new restaurant ...

McDonald’s E. coli incident last year stopped customers in their tracks, leading to the chain’s worst quarterly sales result ...

Recently, the firm has been leaning into its scale-driven cost advantage to emphasize its value offerings amid a challenging consumption spending environment. We view this strategy as prudent.

McDonald’s on Monday reported disappointing quarterly revenue, dragged down by weaker-than-expected sales at its U.S.

McDonald's executives told analysts during an earnings call Monday that the company faced a financial blow from the deadly E. coli outbreak that occurred last year.

Every time I pass a McDonald’s (MCD), it’s the same story — long lines, a buzzing crowd, and a sense of organized chaos. No ...

This is the second best thing you'll put in your mouth in 2024. For real, this made the top 3 bark for so many of us! And ...

Preliminary Q4 2024 results indicate the worst is over for the restaurant industry. Click here for a detailed analysis.

History was made, and I don’t just mean that when it comes to the awards that were earned. Ahead of the event, more than a ...